These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36478401)

  • 1. Application of a split-Cre system for high-capacity adenoviral vector amplification.
    Gonzalez-Aparicio M; Bunuales M; de Landazuri IO; Prieto J; Hernandez-Alcoceba R
    Biotechnol J; 2023 Mar; 18(3):e2200227. PubMed ID: 36478401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses.
    Barjot C; Hartigan-O'Connor D; Salvatori G; Scott JM; Chamberlain JS
    J Gene Med; 2002; 4(5):480-9. PubMed ID: 12221641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cre levels limit packaging signal excision efficiency in the Cre/loxP helper-dependent adenoviral vector system.
    Ng P; Evelegh C; Cummings D; Graham FL
    J Virol; 2002 May; 76(9):4181-9. PubMed ID: 11932383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient in vitro and in vivo excision of floxed sequences with a high-capacity adenoviral vector expressing Cre recombinase.
    Badorf M; Edenhofer F; Dries V; Kochanek S; Schiedner G
    Genesis; 2002 Jul; 33(3):119-24. PubMed ID: 12124944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vector and helper genome rearrangements occur during production of helper-dependent adenoviral vectors.
    Ahn M; Gamble A; Witting SR; Magrisso J; Surendran S; Obici S; Morral N
    Hum Gene Ther Methods; 2013 Feb; 24(1):1-10. PubMed ID: 23249343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a FLP/frt system for generating helper-dependent adenoviral vectors.
    Ng P; Beauchamp C; Evelegh C; Parks R; Graham FL
    Mol Ther; 2001 May; 3(5 Pt 1):809-15. PubMed ID: 11356086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-inactivating helper virus for the production of high-capacity adenoviral vectors.
    Gonzalez-Aparicio M; Mauleon I; Alzuguren P; Bunuales M; Gonzalez-Aseguinolaza G; San Martín C; Prieto J; Hernandez-Alcoceba R
    Gene Ther; 2011 Nov; 18(11):1025-33. PubMed ID: 21525953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene.
    Wang Y; Krushel LA; Edelman GM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3932-6. PubMed ID: 8632992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of adenovirus vectors through Cre-lox recombination.
    Hardy S; Kitamura M; Harris-Stansil T; Dai Y; Phipps ML
    J Virol; 1997 Mar; 71(3):1842-9. PubMed ID: 9032314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
    Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
    Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of viral vectors using recombinase-mediated cassette exchange.
    Nakano M; Odaka K; Takahashi Y; Ishimura M; Saito I; Kanegae Y
    Nucleic Acids Res; 2005 May; 33(8):e76. PubMed ID: 15879348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes.
    Zaupa C; Revol-Guyot V; Epstein AL
    Hum Gene Ther; 2003 Jul; 14(11):1049-63. PubMed ID: 12885345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine helper-dependent vectors production: implications of Cre activity and co-infection on adenovirus propagation.
    Fernandes P; Almeida AI; Kremer EJ; Alves PM; Coroadinha AS
    Sci Rep; 2015 Mar; 5():9135. PubMed ID: 25774853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constructing adenoviral vectors by using the circular form of the adenoviral genome cloned in a cosmid and the Cre-loxP recombination system.
    Tashiro F; Niwa H; Miyazaki J
    Hum Gene Ther; 1999 Jul; 10(11):1845-52. PubMed ID: 10446924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of high-capacity adenoviral vectors as replication-defective monomeric genomes in vitro and in murine liver.
    Jager L; Ehrhardt A
    Hum Gene Ther; 2009 Aug; 20(8):883-96. PubMed ID: 19364285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations.
    Kreppel F; Biermann V; Kochanek S; Schiedner G
    Hum Gene Ther; 2002 Jul; 13(10):1151-6. PubMed ID: 12133268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and Large-Scale Production of High-Capacity Adenoviral Vectors Based on the Human Adenovirus Type 5.
    Ehrke-Schulz E; Zhang W; Schiwon M; Bergmann T; Solanki M; Liu J; Boehme P; Leitner T; Ehrhardt A
    J Vis Exp; 2016 Jan; (107):e52894. PubMed ID: 26863087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus mediated prostate specific enzyme prodrug gene therapy using prostate specific antigen promoter enhanced by the Cre-loxP system.
    Yoshimura I; Ikegami S; Suzuki S; Tadakuma T; Hayakawa M
    J Urol; 2002 Dec; 168(6):2659-64. PubMed ID: 12442005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of loxP insertion upstream of the cis-acting packaging domain on adenovirus packaging efficiency.
    Kanegae Y; Ishimura M; Kondo S; Saito I
    Microbiol Immunol; 2012 Jul; 56(7):447-55. PubMed ID: 22734445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-efficiency Cre/loxP-based system for construction of adenoviral vectors.
    Ng P; Parks RJ; Cummings DT; Evelegh CM; Sankar U; Graham FL
    Hum Gene Ther; 1999 Nov; 10(16):2667-72. PubMed ID: 10566894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.